US Patent Issued to TwinStrand Biosciences on Jan. 20 for "Methods and reagents for characterizing genomic editing, clonal expansion, and associated applications" (Washington Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,101, issued on Jan. 20, was assigned to TwinStrand Biosciences Inc. (Seattle).

"Methods and reagents for characterizing genomic editing, clonal expansion, and associated applications" was invented by Jesse J. Salk (Seattle) and Charles Clinton Valentine III (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for characterizing genome editing, clonal expansion and associated reagents for use in such methods are disclosed herein. Some embodiments of the technology are directed to characterizing a population of cells following an engineered genomic editing event, that includes in some embodiments characterizing genomic alterations occurring...